Dear Directors. Would please advise shareholders of the progress and expected completion of the feasibility study that has been stated will be completed in the second half of 2022.
"The remainder of the feasibility program is expected to be completed during the second half of 2022 which is running on schedule given the breadth and comprehensive nature of these studies."
Once again we continue to WAIT.
- Forums
- ASX - By Stock
- M4M
- No market love for Kogi as iron-steel project ignored
No market love for Kogi as iron-steel project ignored, page-76
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add M4M (ASX) to my watchlist
|
|||||
Last
3.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $125.9M |
Open | High | Low | Value | Volume |
3.7¢ | 3.7¢ | 3.5¢ | $98.56K | 2.794M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
13 | 1426883 | 3.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.6¢ | 100000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 357227 | 0.036 |
10 | 839969 | 0.035 |
4 | 935360 | 0.034 |
6 | 580076 | 0.033 |
2 | 130000 | 0.032 |
Price($) | Vol. | No. |
---|---|---|
0.035 | 228 | 1 |
0.036 | 422500 | 3 |
0.037 | 695828 | 7 |
0.038 | 913485 | 6 |
0.039 | 586000 | 2 |
Last trade - 16.10pm 11/07/2024 (20 minute delay) ? |
Featured News
RNU
Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
TLX
Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
M4M (ASX) Chart |